[go: up one dir, main page]

NO20005954L - Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse - Google Patents

Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse

Info

Publication number
NO20005954L
NO20005954L NO20005954A NO20005954A NO20005954L NO 20005954 L NO20005954 L NO 20005954L NO 20005954 A NO20005954 A NO 20005954A NO 20005954 A NO20005954 A NO 20005954A NO 20005954 L NO20005954 L NO 20005954L
Authority
NO
Norway
Prior art keywords
meiosis
infertility
stimulant
camp
treatment
Prior art date
Application number
NO20005954A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005954D0 (no
Inventor
Christa Hegele-Hartung
Quoc-Lam Cam
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20005954D0 publication Critical patent/NO20005954D0/no
Publication of NO20005954L publication Critical patent/NO20005954L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005954A 1998-05-26 2000-11-24 Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse NO20005954L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98250177 1998-05-26
PCT/EP1999/003138 WO1999061010A2 (fr) 1998-05-26 1999-05-07 TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE

Publications (2)

Publication Number Publication Date
NO20005954D0 NO20005954D0 (no) 2000-11-24
NO20005954L true NO20005954L (no) 2000-11-24

Family

ID=8234594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005954A NO20005954L (no) 1998-05-26 2000-11-24 Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse

Country Status (7)

Country Link
EP (1) EP1098652A2 (fr)
JP (1) JP2002516272A (fr)
KR (1) KR20010043828A (fr)
AU (1) AU5408999A (fr)
CA (1) CA2333320A1 (fr)
NO (1) NO20005954L (fr)
WO (1) WO1999061010A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2002591A3 (cs) 1999-09-16 2002-08-14 Novo Nordisk A/S Pevný produkt, prostředek, vodný roztok a zaváděcí systém
US6544166B1 (en) 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility
ATE357507T1 (de) * 1999-11-25 2007-04-15 Novo Nordisk As Behandlung von menschlicher unfruchtbarkeit
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
WO2001062260A2 (fr) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Amelioration d'un taux d'implantation
AU2001248282A1 (en) 2000-04-06 2001-10-23 Novo-Nordisk A/S Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro
EP1147774A1 (fr) 2000-04-20 2001-10-24 Stichting Dienst Landbouwkundig Onderzoek Méthode d'amélioration de la qualité du sperme pour l'insémination artificielle des animaux
WO2001088098A2 (fr) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilisation d'oocytes ages
EP1245572A1 (fr) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Composés aminostérols, leur utilisation pour la préparation des médicaments pour la régulation de la méiose et un procédé de leur préparation
ES2293965T3 (es) * 2001-12-14 2008-04-01 Laboratoires Serono Sa Metodo de inducir la ovulacion utilizando un modulador no polipeptidico de los niveles de camp.
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
US9624278B2 (en) 2011-08-30 2017-04-18 Centre National De La Recherche Scientifique Protein complex comprising MCM8 and MCM9 proteins and their use
GB201117453D0 (en) * 2011-10-10 2011-11-23 Univ Dundee Improved sperm function/activity
CN108531447B (zh) * 2018-04-13 2021-11-23 上海市生物医药技术研究院 调节精子运动能力及辅助生殖的化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196530A3 (fr) * 1985-03-26 1989-03-22 CTA Finanz AG Agent et procédé pour augmenter la croissance, optimiser la fécondité et stimuler le système immunitaire chez les humains et les animaux
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
BR9607673A (pt) * 1995-03-06 1998-06-16 Novo Nordisk As Processo para estimular a meiose de uma célula germinativa e uso de um composto que causa o acúmulo de uma substância endógena ativadora de meiose
US5800625A (en) * 1996-07-26 1998-09-01 Cauldron Limited Partnership Removal of material by radiation applied at an oblique angle
CA2199663C (fr) * 1997-03-11 2004-08-10 Ruth Miriam Moses Maturation et fecondation in vitro d'ovocytes mammaliens

Also Published As

Publication number Publication date
WO1999061010A2 (fr) 1999-12-02
KR20010043828A (ko) 2001-05-25
NO20005954D0 (no) 2000-11-24
AU5408999A (en) 1999-12-13
WO1999061010A3 (fr) 2000-04-27
CA2333320A1 (fr) 1999-12-02
JP2002516272A (ja) 2002-06-04
EP1098652A2 (fr) 2001-05-16

Similar Documents

Publication Publication Date Title
NO20005954L (no) Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse
DK0927309T3 (da) Skrue med selvskærende gevind
ID28949A (id) Artikel-artikel penyerap yang menjaga atau memperbaiki kesehatan kulit
IS1852B (is) Spíró-asabísýklísk efnasambönd sem eru gagnleg við meðferð
DK0792144T3 (da) Rengøringsvæv behandlet med vand-i-lipid emulsion
IS1995B (is) Tríazól afleiður, gagnlegar í meðhöndlun
ID26130A (id) Penyempurnaan-penyempurnaan dalam alat pengantar obat
BR9204375A (pt) Composicao e processo para o tratamento de agua de refrigeracao
DE69700671D1 (de) Sicherungsmutter
PT1235831E (pt) Novos compostos de oxabispidina uteis no tratamento de arritmias cardiacas
DE69903301D1 (de) Fenster hoher zerstäubungs- und ätz-festigkeit für plasma behandlungskammern
PT1015467E (pt) Derivados de eritromicina em ponte 6,9-
NO970631D0 (no) Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
DE69805242D1 (de) Titanaluminidlegierung
PT1211946E (pt) Processo de tratamento de carne fresca
ATA102298A (de) Fenster oder tür
IT237536Y1 (it) Portone sezionale perfezionato
BR9708146A (pt) Processo de tratamento de resfriado comum ou de rinite alérgica
DK1102746T3 (da) Substituerede phenylamidiner med antitrombotisk virkning
ID28335A (id) Pengobatan serangan panik
ES1044515Y (es) Pantalon para el tratamiento topico de la celulitis
KR960017879U (ko) 문짝 프레임의 결합 구조
DK0859899T3 (da) Dørlås som valgfrit kan anvendes højre- eller venstregående
FI2391U1 (fi) Kehysoven rakenne

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application